306 related articles for article (PubMed ID: 25792311)
1. Bioethics. Embryo engineering alarm.
Vogel G
Science; 2015 Mar; 347(6228):1301. PubMed ID: 25792311
[No Abstract] [Full Text] [Related]
2. Bioethics. Embryo engineering study splits scientific community.
Kaiser J; Normile D
Science; 2015 May; 348(6234):486-7. PubMed ID: 25931531
[No Abstract] [Full Text] [Related]
3. Calls for caution in genome engineering should be a model for similar dialogue on pandemic pathogen research.
Lipsitch M; Esvelt K; Inglesby T
Ann Intern Med; 2015 Nov; 163(10):790-1. PubMed ID: 26344802
[No Abstract] [Full Text] [Related]
4. Perspective: Embryo editing needs scrutiny.
Doudna J
Nature; 2015 Dec; 528(7580):S6. PubMed ID: 26630598
[No Abstract] [Full Text] [Related]
5. Methods in Enzymology. The use of CRISPR/Cas9, ZFNs, and TALENs in generating site-specific genome alterations. Preface.
Doudna JA; Sontheimer EJ
Methods Enzymol; 2014; 546():xix-xx. PubMed ID: 25398356
[No Abstract] [Full Text] [Related]
6. Genome editing: 4 big questions.
Tauxe W
Nature; 2015 Dec; 528(7580):S17. PubMed ID: 26630595
[No Abstract] [Full Text] [Related]
7. GENETIC ENGINEERING. Germline editing dominates DNA summit.
Travis J
Science; 2015 Dec; 350(6266):1299-300. PubMed ID: 26659031
[No Abstract] [Full Text] [Related]
8. Ethical concerns of American Evangelical Christians relative to genetic interventions and the Human Genome Project, 1974 to the present.
Davis JJ
Ethics Med; 2004; 20(1):23-33. PubMed ID: 15462045
[No Abstract] [Full Text] [Related]
9. CRISPR/Cas faces the bioethics spotlight.
Perkel J
Biotechniques; 2015 May; 58(5):223-7. PubMed ID: 25967900
[No Abstract] [Full Text] [Related]
10. Don't edit the human germ line.
Lanphier E; Urnov F; Haecker SE; Werner M; Smolenski J
Nature; 2015 Mar; 519(7544):410-1. PubMed ID: 25810189
[No Abstract] [Full Text] [Related]
11. CRISPR: gene editing is just the beginning.
Ledford H
Nature; 2016 Mar; 531(7593):156-9. PubMed ID: 26961639
[No Abstract] [Full Text] [Related]
12. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
13. Mini enzyme moves gene editing closer to the clinic.
Ledford H
Nature; 2015 Apr; 520(7545):18. PubMed ID: 25832387
[No Abstract] [Full Text] [Related]
14. Making the cut.
Travis J
Science; 2015 Dec; 350(6267):1456-7. PubMed ID: 26680172
[No Abstract] [Full Text] [Related]
15. FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology.
Grant EV
Food Drug Law J; 2016; 71(4):608-33. PubMed ID: 29140647
[TBL] [Abstract][Full Text] [Related]
16. CRISPR: A path through the thicket.
Mathews DJ; Chan S; Donovan PJ; Douglas T; Gyngell C; Harris J; Regenberg A; Lovell-Badge R
Nature; 2015 Nov; 527(7577):159-61. PubMed ID: 26560284
[No Abstract] [Full Text] [Related]
17. Applications of CRISPR-Cas systems in neuroscience.
Heidenreich M; Zhang F
Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
19. Germline Manipulation and Our Future Worlds.
Harris J
Am J Bioeth; 2015; 15(12):30-4. PubMed ID: 26632358
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic and reproductive cloning: a critique.
Bowring F
Soc Sci Med; 2004 Jan; 58(2):401-9. PubMed ID: 14604625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
